Denmark has the greatest pharma & biotech cluster in Europe
AMONG THE BEST AND MOST INNOVATIVE IN THE WORLD
The Danish pharma and biotech industry is among the best and most innovative in the world. As the European leader in drug development, Denmark offers attractive business solutions for foreign biotech companies including R&D collaborations, establishing European headquarters or entering strategic partnerships. The Danish biotechnology cluster is a major world player, especially in areas such as inflammatory and infectious diseases, CNS research, diabetes care and cancer research.
A number of favourable framework conditions means that a fast, safe and cost-effective drug discovery and drug development is a reality in Denmark, which also is one of the fastest countries to approve clinical trials. In short, Denmark is the place to perform drug discovery and development.
Overview Reasons for placing biotech business activities in Denmark:
In the Øresund Region and with the strong life science environment around Greater Copenhagen, we have access to a vibrant ecosystem underpinned by world-class life science universities, research infrastructure as well as talented and entrepreneurial people who are competent yet pragmatic as they accept the risk and rewards involved. All this combined makes the region attractive for us as the place to set up our hub.